前往化源商城
入驻化源商城

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one

更新时间:2024-01-10 09:00:29

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式
5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式
委托求购
常用名 5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one 英文名 5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one
CAS号 1229937-09-0 分子量 375.37700
密度 N/A 沸点 N/A
分子式 C21H17N3O4 熔点 N/A
MSDS N/A 闪点 N/A

 名称

英文名 5-[4,5-Bis(benzyloxy)-2-pyridinyl]-1,3,4-oxadiazol-2(5H)-one

 物理化学性质

分子式 C21H17N3O4
分子量 375.37700
精确质量 375.12200
PSA 82.37000
LogP 3.71180

 合成线路

~90%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献:Pfizer Inc Patent: US2010/160281 A1, 2010 ; Location in patent: Page/Page column 13-14 ; US 20100160281 A1

~92%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献:Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献:Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献:Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献:Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献:Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献:Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献:Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390